Dupixent vs Pear Therapeutics
Dupixent vs Pear Therapeutics, compared side by side on 8 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Dupixent is on 6/100 and Pear Therapeutics on 49/100.
Where each one leads
Dupixent
- agent readiness: 26/100 against 21/100
Pear Therapeutics
- our overall score: 49/100 against 6/100
At a glance
| Measure | Dupixent | Pear Therapeutics |
|---|---|---|
| What it is | A biologic medicine developed by Sanofi and Regeneron Pharmaceuticals for treating various inflammatory conditions. | Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals. |
| Category | HealthTech, AI Infrastructure, AI Tools, Generative AI | HealthTech, MedTech, Biotech, Digital Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | Not published | 2013 |
| Headquarters | Not published | Boston, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Dupixent | Pear Therapeutics |
|---|---|---|
| Total funding | Not published | $409M |
| Latest round | Not published | Post-IPO Equity |
| Valuation | Not published | $1.6B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Dupixent | Pear Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 6/100 | 49/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 11/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (26/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Dupixent | Pear Therapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| Open source | Yes | No |
Dupixent vs Pear Therapeutics: common questions
Which is better, Dupixent or Pear Therapeutics?
On our 0-100 score Pear Therapeutics rates higher (49/100 against 6/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 8 data points above: read the rows that match what you are buying for.
How do Dupixent and Pear Therapeutics compare on the numbers?
Dupixent leads on agent readiness (26/100 against 21/100). Pear Therapeutics leads on our overall score (49/100 against 6/100).
Read the full Dupixent review and pricing or the Pear Therapeutics review and pricing. You can also browse other Dupixent alternatives we track.